Literature DB >> 657498

A useful method for predicting creatinine clearance in children.

B C Shull, D Haughey, J R Koup, T Baliah, P K Li.   

Abstract

A practical method for predicting creatinine clearance for pediatric patients from serum creatinine concentration and patient age is presented. Creatinine excretion rate (ER) can be predicted from the patient's age, in years, by the formula: ER = (0.035 X age) + 0.236. Using the predicted excretion rate and serum creatinine concentration, creatinine clearance can be predicted. There was good correlation (r = 0.90) between predicted and observed creatinine clearances in 101 subjects with various degrees of renal impairment. This method allows renal function to be rapidly estimated.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 657498

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


  10 in total

Review 1.  Essentials of laboratory medicine for the nephrology clinician.

Authors:  Tarak Srivastava; Uttam Garg; Y Raymond Chan; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

2.  Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.

Authors:  Thomas H Beckham; Dana L Casey; Michael P LaQuaglia; Brian H Kushner; Shakeel Modak; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-11       Impact factor: 7.038

3.  Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Authors:  Trevor N Johnson; Amin Rostami-Hodjegan; Geoffrey T Tucker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.

Authors:  Kannan Sridharan; Amal Al Daylami; Reema Ajjawi; Husain Al-Ajooz; Sindhan Veeramuthu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

5.  Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital.

Authors:  Kannan Sridharan; Amal Al-Daylami; Reema Ajjawi; Husain Am Al Ajooz
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.022

6.  Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease.

Authors:  Katherine A Lindle; Kim Dinh; Brady S Moffett; W Buck Kyle; Natalie M Montgomery; Susan D Denfield; Jarrod D Knudson
Journal:  Pediatr Cardiol       Date:  2014-03       Impact factor: 1.655

7.  Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinism.

Authors:  Chee M Ng; Fei Tang; Steven H Seeholzer; Yixuan Zou; Diva D De León
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

8.  Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis.

Authors:  Michael Makanga; Quique Bassat; Catherine O Falade; Zulfiqarali G Premji; Srivicha Krudsood; Philip Hunt; Verena Walter; Hans-Peter Beck; Anne-Claire Marrast; Marc Cousin; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 9.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

Review 10.  Cystatin C: a new renal marker and its potential use in small animal medicine.

Authors:  L Ghys; D Paepe; P Smets; H Lefebvre; J Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.